Viral and Non-viral Vectors in Gene Therapy: Technology Development and Clinical Trials

Technology in Cancer Research and Treatment

Volumn 2, Issue 5, 2003, Pages 471-485

  Lundstrom, Kenneth ^a   Boulikas, Teni ^b  

^a BioXtal   (Switzerland)

^b Regulon Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGODEOXYNUCLEOTIDE; LIPOSOME; RIBOZYME; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER IMMUNOTHERAPY; CANCER PATIENT; CELL COMPARTMENTALIZATION; CHRONIC DISEASE; CONTROLLED STUDY; DNA SEQUENCE; DRUG DELIVERY SYSTEM; GENE EXPRESSION REGULATION; GENE TARGETING; GENE TRANSFER; IMMUNOSTIMULATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; REVIEW; VIRAL GENE THERAPY;

EID: 0242298666     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.1177/153303460300200513     Document Type: Review

References (104)

1. Boulikas, T. Status of Gene Therapy in 1997: Molecular Mechanisms, Disease Targets, and Clinical Applications. Gene Ther. Mol. Biol. 1, 1-172 (1998).
2. Choisy-Rossi, C., Reisdorf, P., Yonisch-Rouach, E. The p53 Supperssor Gene: Structure, Function and Mechanism of Action. Results Probl. Cell Differ. 23, 145-172 (1999).
3. Wang, S. C., Zhang, L., Hortobagyi, G. N., Hung, M. C. Targeting HER2: Recent Developments and Future Directions for Breast Cancer Patients. Semin. Oncol. 28 (Suppl 18), 21-29 (2001).
4. Hubberstey, A. V., Pavliv, M, Parks, R. J. Cancer Therapy Utilizing an Adenoviral Vector Expressing Only E1A. Cancer Gene Ther 9, 321-329 (2002).
5. Paul, S., Regulier, E., Poitevin, Y., Hormann, H., Acres, R. B. The Combination of a Chemokine, Cytokine and TCR-based T-Cell Stimulus for Effective Gene Therapy of Cancer. Cancer. Immunol. Immunother. 51, 645-654 (2002).
6. Lundqvist, A., Choudhury, A., Nagata, T., Andersson, T., Quinn, G., Fong, T., Maitland, N., Pettersson, S., Paulie, S., Pisa, P. Recombinant Adenovirus Vector Activates and Protects Human Monocyte-derived Dendritic Cells from Apoptosis. Hum. Gene Ther. 13, 1541-1549 (2002).
7. Kershaw, M. H., Wang, G., Westwood, J. A., Pachynski, R. K., Tiffany, H. L., Marincola, F. M., Wang, E., Young, H. A., Murphy, P. M., Hwu, P. Redirecting Migration of T-Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2. Hum. Gene Ther. 13, 1971-1980 (2002).
8. Janssens, W., Chuah, M. K., Naldini, L., Follenzi, A., Collen, D., Saint-Remy, J. M., Van den Driessche, T. Efficiency of Onco-retroviral and Lentiviral Gene Transfer into Primary Mouse and Human B-lymphocytes is Pseudotype Dependent. Hum. Gene Ther. 14, 263-276 (2003).
9. Satoh, T., Timme, T. L., Saika, T., Ebara, S., Yang, G., Wang, J., Ren, C., Kusaka, N., Mouraviev, V., Thompson, T. C. Adenoviral Vector-Mediated mRTVP-1 Gene Therapy for Prostate Cancer. Hum. Gene Ther. 14, 91-101 (2003).
10. Ajiki, T., Murakami, T., Kobayashi, Y., Hakamata, Y., Wang, J., Inoue, S., Ohtsuki, M., Nakagawa, H., Kariya, Y., Hoshino, Y., Kobayashi, E. Long-lasting Gene Expression by Particle-mediated Intramuscular Transfection Modified with Bupivacaine: Combinatorial Gene Therapy with IL-12 and IL-18 cDNA Against Rat Sarcoma at a Distant Site. Cancer Gene Ther. 10, 318-329 (2003).
11. Lee, J. C., Park, K. H., Han, S. J., Yoo, C. G., Lee, C. T., Han, S. K., Shim, Y. S., Kim, Y. W. Inhibitory Effect of Adenovirus-uteroglobin Transduction on the Growth of Lung Cancer Cell Lines. Cancer Gene Ther 10, 287-293 (2003).
12. Berg, R. W., Ferguson, P. J., Vincent, M. D., Koropatnick, D. J. A "Combination Oligonucleotide" Antisense Strategy to Downregulate Thymidylate Synthase and Decrease Tumor Cell Growth and Drug Resistance. Cancer Gene Ther. 10, 278-286 (2003).
13. Nagata, J., Kijima, H., Hatanaka, H., Asai, S., Miyachi, H., Abe, Y., Yamazaki, H., Nakamura, M., Watanabe, N., Mine, T., Kondo, T., et al. Reversal of Drug Resistance Using Hammerhead Ribozymes Against Multidrug Resistance-associated Protein and Multidrug Resistance 1 Gene. Int. J. Oncol. 21, 1021-1026, (2002).
14. Schondorf, T., Neumann, R., Benz, C., Becker, M., Riffelmann, M., Gohring, U. J., Sartorius, J., von Konig, C. H., Breidenbach, M., Valter, M. M., Hoopmann, M., Di Nicolantonio, F., Kurbacher, C. M. Cisplatin, Doxorubicin and Paclitaxel Induce mdr1 Gene Transcription in Ovarian Cancer Cell Lines. Recent Results Cancer Res. 161, 111-116, (2003).
15. Choi, K. S., Lee, T. H., Jung, M. H. Ribozyme-mediated Cleavage of the Human Survivin mRNA and Inhibition of Antiapoptotic Function of Survivin in MCF-7 Cells. Cancer Gene Ther. 10, 87-95 (2003).
16. Berglund, P., Smerdou, C., Fleeton, M. N., Tubulekas, I, Liljeström, P. Enhancing Immune Response using Suicidal Vaccines. Nat. Biotechnol. 16, 562-565 (1998).
17. Hariharan, M. J., Driver, D. A., Townsend, K., Brumm, D., Polo, J. M., Belli, B. A., Catton, D. J., Hsu, D., Mittelstaedt, D., McCormack, J. E., Karavodin, L., Dubensky, T. W. Jr., Chang, S. M. W., Banks, T. A. DNA Immunization Against Herpes Simplex Virus: Enhanced Efficacy Using Sindbis Virus-based Vector. J. Virol. 72, 950-958 (1998).
18. Leitner, W. W., Ying, H., Restifo, N. P. DNA and RNA Based Vaccines: Principles, Progress and Prospects. Vaccine 18, 765-777 (1999).
19. Ying H., Zaks, T. Z., Wang, R.-F., Irvine, K. R., Kammula, U. S., Marincola, F. M., Leitner, W. W., Restifo, N. P. Cancer Therapy using Self-replicating RNA Vaccine. Nat. Med. 5, 823-827 (1999).
20. Lundstrom, K. Alphavirus Vectors for Vaccine Production and Gene Therapy. Expert Rev. Vaccines 2, 447-459 (2003).
21. Check, E. Gene Therapy: A Tragic Setback. Nature 420, 116-118 (2002).
22. Rabinowtz, J. E., Samulski, J. Adeno-associated Virus Expression Systems for Gene Transfer. Curr. Opin. Biotechnol. 9, 470-475 (1998).
23. Davidson B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., Zabner, J., Ghodsi, A., Ghiorini, J. A. Recombinant Adeno-associated Virus Type 2, 4 and 5 Vectors: Transduction of Variant Cell Types and Regions in the Mammalian Central Nervous System. Proc. Natl. Acad. Sci. USA 97, 3428-3432 (2000).
24. Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., Wilson, J. M. Novel Adeno-associated Viruses from Rhesus Monkeys as Vectors for Human Gene Therapy. Proc. Natl. Acad. Sci. USA 99, 11854-11859 (2002).
25. Wendtner, C. M., Kofler, D. M., Theiss, H. D., Kurzeder, C., Buhmann, R., Schweighofer, C., Parabo, L., Danhauser-Riedl, S., Baumert, J., Hiddemann, H., Hallek, M., Buning, H. Efficient Gene Transfer of CD40 Ligand into Primary B-CLL Cells Using Recombinant Adeno-associated Virus (rAAV) Vectors. Blood 100, 1655-1661 (2002).
26. Zavorotinskaya T, Tomkinson, A., Murphy, J. E. Treatment of Experimental Asthma by Long-term Gene Therapy Directed Against IL-4 and IL-13. Mol. Ther 7, 155-162 (2003).
27. Takahashi, H., Hirai, Y., Migita, M., Seino, Y., Fukuda, Y., Sauraba, H., Kase, A., Kobayashi, T., Hashimoto, Y., Shimada, T. Long-term Systemic Therapy of Fabry Disease in a Knockout Mouse by Adenoassociated Virus-mediated Muscle-directed Gene Transfer. Proc. Natl. Acad. Sci. USA 99, 13777-13782 (2002).
28. Martin, K. R., Klein, R. L., Quigley, H. A. Gene Delivery to the Eye using Adeno-associated Viral Vectors. Methods 28, 267-275 (2002).
29. Schiedner, G., Morral, N., Parks, R. J., Wu, Y., Koopmans, S. C., Langston, C., Graham, F. L., Beaudet, A. L., Kochanek, S. Genomic DNA Transfer with a High-capacity Adenovirus Vector Results in Improved In Vivo Gene Expression and Decreased Toxicity. Nat. Genet. 18, 180-183 (1998).
30. Brade, A. M., Szmitko, P., Ngo, D., Liu, F. F., Klamut, H. J. Heat-directed Suicide Gene Therapy for Breast Cancer. Cancer Gene Ther. 10, 294-301 (2003).
31. Miyagi, T., Koshida, K., Hori, O., Konaka, H., Katoh, H., Kitagawa, Y., Mizoka, A., Egawa, M., Ogawa, S., Hamada, H., Namiki, M. Gene Therapy for Prostate Cancer using the Cytosine Deaminase/ uracil Phosphoribosyltransferase Suicide System. J. Gene Med. 5, 30-37 (2003).
32. Chester, J. D., Kennedy, W., Hall, G. D., Selby, P. J., Knowles, M. A. Adenovirus-mediated Gene Therapy for Bladder Cancer: Efficient Gene Delivery to Normal and Malignant Human Urothelial Cells In Vitro and Ex Vivo. Gene Ther. 10, 172-179 (2003).
33. Dirven, C., Van Beusechem, V., Lamfers, M., Grill, J., Gerritsen, W., Vandert, W. Oncolytic Adenoviruses for Treatment of Brain Tumors. Expert Opin. Biol. Ther. 2, 943-952 (2002).
34. Ando, D., Kirn, D. The Oncolytic Virotherapy Treatment Platform for Cancer: Unique Biological and Biosafety Points to Consider. Cancer Gene Ther. 9, 1062-1067 (2002).
35. Yoon, T. K., Shichinohe, T., Laquerre, S., Kasahara, N. Selectively Replicating Adenoviruses for Oncolytic Therapy. Curr. Cancer Drug Targets 1, 85-107 (2001).
36. Bernt, K. M., Steinwaerder, D. S., Ni, S., Li, Z. Y., Roffler, S. R., Lieber, A. Enzyme-activated Prodrug Therapy Enhances Tumor-specific Replication of Adenovirus Vectors. Cancer Res. 62, 6089-6098 (2002).
37. Lundstrom, K. Alphavirus-based Vaccines. Curr. Opin. Mol. Ther. 4, 28-34 (2002).
38. Liljeström, P., Garoff, H. A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon. Bio/Technology 9, 1356-1361 (1991).
39. Xiong, C., Levis, R., Shen, P., Schlesinger, S., Rice, C. M., Huang, H. V. Sindbis Virus: An Efficient, Broad Host Range Vector for Gene Expression in Animal Cells. Science 243, 1189-1191 (1989).
40. Davis, N. L., Brown, K. W., Johnston, R. E. In vitro Synthesis of Infectious Venezuelan Equine Encephalitis Virus RNA from a cDNA Clone: Analysis of a Viable Deletion Mutant. Virology 171, 189-204 (1989).
41. Strauss, J. H., Strauss, E. G. The Alphaviruses: Gene Expression, Replication, and Evolution. Microbiol. Rev. 58, 491-562 (1994).
42. Lundstrom, K., Richards, J. G, Pink, J. R., Jenck, F. Efficient In Vivo Expression of a Reporter Gene in Rat Brain After Injection of Replication-deficient Semliki Forest Virus. Gene Ther Mol. Biol. 3. 15-23 (1999).
43. Colmenero, P., Chen, M., Castanos-Velez, E., Liljeström, P., Jondahl, M. Immunotherapy with Recombinant SFV-replicons Expressing the P185A Tumor Antigen or IL-12 Induces Tumor Regression. Int. J. Cancer 98, 554-560 (2002).
44. Yamanaka, R., Zullo, S. A., Tanaka, R., Blese, M., Xanthopoulos, K. G. Enhancement of Antitumor Response in Glioma Models in Mice by Genetically Modified Dendritic Cells Pulsed with Semliki Forest Virus-mediated Complementary DNA. J. Neurosurg. 94, 478-481 (2001).
45. Colmenero, P., Liljeström, P., Jondal, M. Induction of P185 Tumor Immunità by Recombinant Semliki Forest Virus Expressing P1A Gene. Gene Ther. 6, 1728-1733 (1999).
46. Velders, M. P., McElhiney, S., Cassetti, M. C., Eiben, G. L., Higgins, T., Kovacs, G. R., Elmishad, A. G., Kast, W. M., Smith, L. R. Eradication of Established Tumors by Vaccination with Venezuelan Equine Encephalitis Virus Replicon Particles Delivering Human Papillomavirus 16 E7 RNA. Cancer Res. 61, 7861-7867 (2001).
47. Asselin-Paturel, C., Lassau, N., Guinebretiere, J.-M., Zhang, J., Gay, F., Bex, F., Hallez, S., et al. Transfer of the Murine Interleukin-12 gene In Vivo by a Semliki Forest Virus Vector Induces B16 Tumor Regression Through Inhibition of Tumor Blood Vessel Formation Monitored by Doppler Ultrasonography. Gene Ther 6, 606-615 (1999).
48. Murphy, A.-M., Morris-Downes, M. M., Sheahan, B. J., Atkins, G. J. Inhibition of Human Lung Carcinoma Cell Growth by Apoptosis Induction Using Semliki Forest Virus Recombinant Particles. Gene Ther. 7, 1477-1482 (2000).
49. Murphy, A. M., Sheahan, B. J., Atkins, G. Induction of Apoptosis in Bcl-2-expressing Rat Prostate Cancer Cells using the Semliki Forest Virus Vector. Int. J. Cancer 94, 572-578 (2001).
50. Ohno, K., Sawai, K., Ijima, Y., Levin, B., Meruelo, D. Cell-specific Targeting of Sindbis Virus Vectors Displaying IgG Binding Domains of Protein A. Nat. Biotechnol. 15, 763-767 (1997).
51. Lundstrom, K., Boulikas, T. Breakthrough in Cancer Therapy: Encapsulation of Drugs and Viruses. Curr. Drug Discovery November issue, pp19-23 (2002).
52. Krisky, D. M. et al. Deletion of Early Genes from Herpes Simplex Virus Reduces Cytotoxicity and Permits Long-term Gene Expression in Neurons. Gene Ther. 5, 1593-1603 (1998).
53. Harland, J., Papanastassiou, V., Brown, S. M. HSV1716 Persistance in Primary Human Glioma Cells In Vitro. Gene Ther. 9, 1194-1198 (2002).
54. Niranjan, A., Moriuchi, S., Lunsford, L. D., Kondziolka, D., Flickinger, J. C., Fellows, W., Rajendiran, S., Tamura, M., Cohen, J. B., Glorioso, J. C. Effective Treatment of Experimental Glioblastoma by Herpes Simplex Virus type-1 Vector-mediated TNFalpha and HSV-tk Gene Transfer in Combination with Radiosurgery and Ganciclovir Administration. Mol. Ther. 2, 114-120 (2000).
55. Akkaraju, G. R., Huard, J., Hoffman, E. P., Goins, W. F., Pruchnic, R., Watkins, S. C., Cohen, J. B., Glorioso, J. C. Herpes Simplex Virus Vector-mediated Dystrophin Gene Transfer and Expression in MDX Mouse Skeletal Muscle. J. Gene Med. 1, 280-289 (1999).
56. + Cells as Cellular Vehicles for Gene Delivery Into Areas of Angiogenesis in a Rhesus Model. Gene Ther. 7, 43-52 (2000).
57. Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., Yee, J. K. Vesicular Stomatitis Virus G Glycoprotein Pseudotyped Retroviral Vectors: Concentration to Very High Titer and Efficient Gene Transfer into Mammalian and Nonmammalian Cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037 (1993).
58. Hu, W.-S., Pathak, V. K. Design of Retroviral Vectors and Helper Cells for Gene Therapy. Pharmacol. Rev. 52, 493-511 (2000).
59. Bonini, C., Ferrari, G., Verzeletti, S., Servida, P., Zappone, E., Ruggieri, L., Ponzoni, M., Rossigni, S., Mavilio, F., Traversari, C., Bordignon, C. HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-versus-leukemia. Science 276, 1719-1723 (1997).
60. Solly, S. K., Trajcevski, S., Frisen, C., Holzer, G. W., Nelson, E., Clerc, B., Abordo-Abesida, E., Castro, M., Lowenstein, P., Klatzmann, D. Replicative Retroviral Vectors for Cancer Gene Therapy. Cancer Gene Ther. 10, 30-39 (2003).
61. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J. L., Bousso, P., Deist, F. L., Fischer, A. Gene Therapy of Human Severe Combined Immune Deficiency (SCID)-X1 Disease. Science 288, 669-672 (2000).
62. Vigna, E., Naldini, L. Lentiviral Vectors: Excellent Tools for Experimental Gene Transfer and Promising Candidates for Gene Therapy. J. Gene Med. 2, 308-316 (2000).
63. Sauter, S. L., Gasmi, M. FIV Vector Systems. Somat. Cell Mol. Genet. 26, 99-129 (2001).
64. Ikeda, Y., Collins, M. K., Radcliffe, P. A., Mitrophanous, K. A., Takeuchi, Y. Gene Transduction Efficiency in Cells of Different Species by HIV and EIAV. Gene Ther. 9, 932-938 (2002).
65. Follenzi, A. Efficient Gene Delivery and Targeted Expression to Hepatocytes In Vivo by Improved Lentivirus Vectors. Hum. Gene Ther. 13, 243-260 (2002).
66. Indraccolo, S., Habeler, W., Tisato, V., Stivano, L., Piovan, E., Tosello, V., Esposito, G., et al. Gene Transfer in Ovarian Cancer Cells: A Comparison Between Retroviral and Lentiviral Vectors. Cancer Res. 62, 6099-6107 (2002).
67. Kordower, J. H. et al. Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's Disease. Science 290, 767-773 (2000).
68. Kwak, H., Honig, H., Kaufmann, H. L. Poxviruses as Vectors for Cancer Immunotherapy. Curr. Opin. Drug Discov. Devel. 6, 161-168 (2003).
69. Zeh, H. J., Bartlett, D. L. Development of a Replication-selective, Oncolytic Poxvirus for the Treatment of Human Cancers. Cancer Gene Ther 9, 1001-1012 (2002).
70. Mastrangelo, M. J., Lattime, E. C. Virotherapy Clinical Trials for Regional Disease: In Situ Immune Modulation using Recombinant Poxvirus Vectors. Cancer Gene Ther 9, 1013-1021 (2002).
71. Drexler, I., Antunes, E., Schmitz, M., Wölfel, T., Huber, C., Erfle, V., Rieber, P., Theobaldi, M., Sutter, G. Modified Vaccinia Virus Ankara for Delivery of Human Tyrosinase as Melanoma-associated Antigen: Induction of Tyrosinase- and Melanoma-specific Human Leukocyte Antigen A* 0201-restricted Cytotoxic T-Cells In Vitro and In Vivo. Cancer Res. 59, 4955-4963 (1999).
72. Ikonomou, L., Schneider, Y. J., Agathos, S. N. Insect Cell Culture for Industrial Production of Recombinant Proteins. Appl. Microbiol. Biotechnol., in press, (2003).
73. Lehtolainen, P., Tyynela, K, Kannasto, J., Airenne, K. J., Yla-Herttuala, S. Baculoviruses Exhibit Restricted Cell Type Specificity in Rat Brain: Comparison of Baculovirus- and Adenovirus-mediated Intracerebral Gene Transfer In Vivo. Gene Ther. 9, 1693-1699 (2002).
74. Roder, G., Keil, O., Prisack, H. B., Bauerschmitz, G., Hanstein, B., Nestle-Kramling, C., Hemminki, A., Bender, H. G., Niederacher, D., Dall, P. Novel cGMP Liposomal Vectors Mediate Efficient Gene Transfer. Cancer Gene Ther. 10, 312-317 (2003).
75. Zeisig, R., Ress, A, Fichtner, I, Walther, W. Lipoplexes with Alkylphospholipid as New Helper Lipid for Efficient In Vitro and In Vivo Gene Transfer in Tumor Therapy. Cancer Gene Ther. 10, 302-311 (2003)
76. Stopeck, A. T., Jones, A., Hersh, E. M., Thompson, J. A., et al. Phase II Study of Direct Intralesional Gene Transfer of Allovectin-7, an HLA-B7/b2-microglobulin DNA-liposome Complex in Patients with Metastatic Melanoma. Clin. Cancer Res. 7, 2285-2291 (2001).
77. Stopeck, A. T., Hersh, E. M., Akporiaye, E. T., Harris, D. T., et al. Phase I Study of Direct Gene Transfer of an Allogeneic Histocompatibility Antigen, HLA-B7, In Patients with Metastatic Melanoma. J. Clin. Oncol. 15, 341-349 (1997).
78. D'Urso, C. M., Wang, Z. G., Cao, Y., Tatake, R., Zeff, R. A., Ferrone, S. Lack of HLA Class I Antigen Expression by Cultured Melanoma Cells FO-1 Due to a Defect in B2m Gene Expression. J. Clin. Investig. 87, 284-292 (1991).
79. Iseki, G., Sugawara, M, Saitoh, N., Miyazaki, K. The Transport Mechanism of Organic Cations and Their Zwitterionic Derivatives Across Rat Intestinal Brush-border Membrane. 1. Binding Characteristics to the Bio- and Lipid-membranes. Biochim. Biophys. Acta 1146, 121-126 (1993).
80. Alexandridous, S., Mange, F., Foissy, A. Surface Characterization of Oil-containing Polytherephtalamide Microcapsules Prepared by Interfacial Polymerization. J. Microencapsul. 18, 767-781 (2001).
81. Rittner, K., Benavente, A., Bompard-Sorlet, A., Heitz, F., et al. New Basic Membrane-destabilizing Peptides for Plasmid-based Gene Delivery In Vitro and In Vivo. Mol. Ther. 5, 104-114 (2002).
82. Martin, F., Boulikas, T. The Challenge of Liposomes in Gene Therapy. Gene Ther. Mol. Biol. 1, 173-214 (1998).
83. Allen, T. M., Chonn, A. Large Unilamellar Liposomes with Low Uptake into the Reticuloendothelial System. FEBS Lett. 223, 42-46 (1987)
84. Gabizon, A., Shiota, R., Papahadjopoulos, D. Pharmacokinetics and Tissue Localization of Doxorubicin Encapsulated in Stable Liposomes with Long Circulation Times. J. Natl. Cancer Inst. 81, 1484-1488 (1989).
85. Beauchamp, C. O., Gonias, S. L., Menapace, D. P., Pizzo, S. V. A New Procedure for the Synthesis of Polyethylene Glycol-protein Adducts; Effects on Function, Receptor Recognition, and Clearance of Superoxide Dismutase, Lactoferrin, and Alpha 2-macroglobulin. Anal. Biochem. 131, 25-33 (1983).
86. Gabizon, A., Papahadjopoulos, D. Liposome Formulations with Prolonged Circulation Time in Blood and Enhanced Uptake by Tumors. Proc. Natl. Acad. Sci. USA 85, 6949-6953 (1988).
87. Klibanov, A. L., Maruyama, K., Torchilin, V. P., Huang, L. Amphipathic Polyethyleneglycols Effectively Prolong the Circulation Time of Liposomes. FEBS Lett. 268, 235-237 (1990).
88. Lasic, D. D., Martin, F. J., Gabizon, A, Huang, S. K., Papahadjopoulos, D. Sterically Stabilized Liposomes: A Hypothesis on the Molecular Origin to the Extended Circulation Times Biochim. Biophys. Acta 1070, 187-192 (1991)
89. Torchilin, V. P., Klibanov, A. L., Huang, L., O'Donnell, S., Nossiff, N. D., Khaw, B. A. Targeted Accumulation of Polyethylene Glycol-coated Immunoliposomes in Infarcted Rabbit Myocardium. FASEB J. 6, 2716-2719 (1992).
90. Boulikas, T., Stathopoulos, G. P., Deliconstantinos, G., Rigatos, S., Darli, E., Viliotou, V., Vougiouka, M. A New Liposomal Cisplatin Lacks Renal Toxicity and Other Serious Adverse Reactions: A Phase I Study. (Submitted) (2003).
91. Boulikas, T. Anticancer Activity of a Novel Liposomal Cisplatin (Lipoplatin) and Tumor Targeting with Liposomal Genes in Mouse Xenografts. Submitted (2003).
92. Yotnda, P., Chen, D.-H., Chiu, W., Pietra, P., Davis, A., Smyth Templeton, N., Brenner, M. K. Bilamellar Cationic Liposomes Protect Adenovectors from Preexisting Humoral Immune Responses. Mol. Ther. 5, 233-241 (2002).
93. Abrahams, J. M., Song, C., DeFelice, S., Grady, M. S., Diamond, S. L., Levy, R. J. Endovascular Microcoil Gene Delivery Using Immobilized Anti-adenovirus Antibody for Vector Tethering. Stroke 33, 1376-1382 (2002).
94. Brickelmaier, M., Carmillo, A., Goelz, S., Barsoum, J., Qin, X. Q. Cytotoxicity of Combinations of IFN-beta and Chemotherapeutic Drugs. J. Interferon Cytokine Res. 22, 873-80 (2002).
95. Kigawa, J., Sato, S., Shimada, M., Takahashi, M., Itamochi, H., Kanamori, Y., Terakawa, N. p53 Gene Status and Chemosensitivity in Ovarian Cancer. Hum. Cell 14, 165-71 (2002).
96. Song, K., Fukushima, P., Seth, P., Sinha, B. K. Role of p53 and Apoptosis in Sensitization of Cis-diamminedichloroplatinum Antitumor Activity by Interleukin-1 in Ovarian Carcinoma Cells. Int. J. Oncol. 12, 299-304 (1998).
97. Biesma, B., van Kralingen, K. W., van Leen, R. W., Koster, M. C., Postmus, P. E. Recombinant Human Interleukin-3 Administered Concomitantly with Chemotherapy in Patients with Relapsed Small Cell Lung Cancer. J. Exp. Ther. Oncol. 2, 47-52 (2002).
98. Timiryasova, T. M., Gridley, D. S., Chen, B., Andres, M. L., Dutta-Roy, R., Miller, G., Bayeta, E. J. M., Fodor, I. Radiation Enhances the Anti-tumor Effects of Vaccinia-p53 Gene Therapy in Glioma. Technol. Cancer Res. Treatment 2, 223-235 (2003).
99. www.wiley.co.uk/genmed (Journal of Gene Medicine)
100. Buller, R. E., Shahin, M. S., Horowitz, J. A., Runnebaum, I. B., Mahavni, V., Petrauskas, S., Kreienberg, R., Karlan, B., Slamon, D., Pegram, M. Long Term Follow-up of Patients with Recurrent Ovarian Cancer After Ad p53 Gene Replacement with SCH 58500. Cancer Gene Ther. 9, 567-572 (2002a).
101. Buller, R. E., Runnebaum, I. B., Karlan, B. Y., Horowitz, J. A., Shahin, M., Buekers, T., Petrauskas, S., Kreienberg, R., Slamon, D., Pegram, M. A Phase I/II Trial of rAd/p53 (SCH 58500) Gene Replacement in Recurrent Ovarian Cancer. Cancer Gene Ther 9, 553-566 (2002b).
102. Yoo, G. H., Hung, M. C., Lopez-Berestein, G., LaFollette, S., Ensley, J. F., Carey, M., Batson, E., Reynolds, T. C., Murray, J. L. Phase I Trial of Intratumoral Liposome E1A Gene Therapy in Patients with Recurrent Breast and Head and Neck Cancer. Clin. Cancer Res. 7, 1237-1245 (2001).
103. Flotte, T. R., Zeitlin, P. L., Reynolds, T. C., Heald, A. L., Pedersen, P., Beck, S., Conrad, C. K., et al. Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-associated Virus Serotype 2 (rAAV2)-CFTR Cector in Adult Cystic Fibrosis Patients: A Two-part Clinical Study. Hum. Gene Ther. 14, 1079-1088 (2003).
104. www.vical.com/products/allovectin7/htm